Home
Company Info
Company Evolution
Company Profile
Management Team
Business Strategy
Corporate Governance
Media Centre
Events
Media Contact
Investor Relations
Investor Home
Press Release Archive
Company Facts Report
Broker Forecasts
Email Alerts
Trading Info
Annual & Interim Reports
Advisers & Registrars
Company Presentations
Financial Calendar
Shareholder FAQs
Contact Details
Research & Development
Preclinical Research
Selected Publications
Research Programmes
Product Portfolio
Commercialisation
Commercialisation Overview
Outlicensing
Contact Us
Glossary
Navigation menu
Discover more about Ark Therapeutics products here
Ark Therapeutics, From science To patients
Ark announces NHS reimbursement and launch of KerraMax® Super-absorbent Dressing
20 October 2008
Ark secures reimbursement for Neuropad® from UK NHS Business Services Authority
02 October 2008
Vitor™ commences patient enrolment into Phase III pilot study
27 August 2008
Read more news stories here
2008 Interim Management Statement published.
13 November 2008
2008 Interim Report published.
27 August 2008
2007 Annual Report published.
20 March 2008
Visit the Investor Relations section of the web site.
2008 Interim Results presentation
27 August 2008
39.00 p
Change: 0.50p
Last Trade: 21/11/2008 22:18
View share price data
Use the search form below to search our site.
Search
Download the latest Annual Report & Accounts
[1.7MB]
Keep up-to-date with product developments, investor relations information and news with our email updates.
Register here to receive our email alerts.
©2008 Ark Therapeutics Group plc. All rights reserved | Site Design and Maintenance by
3wise Internet Solutions
To view PDF files on this site, you will need Adobe Acrobat Reader.
Download it for free here.
Stats Script
Stats Script